Research ArticleArticle
Methotrexate and Injectable Tumor Necrosis Factor-α Inhibitor Adherence and Persistence in Children with Rheumatic Diseases
Sarah Ringold, Shannon Grant, Charmaine Girdish, Carol A. Wallace and Sean D. Sullivan
The Journal of Rheumatology November 2012, jrheum.120753; DOI: https://doi.org/10.3899/jrheum.120753
Sarah Ringold
From Seattle Children’s Hospital, Pediatrics; Axio Research LLC; Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; University of Washington Department of Pharmacy, Seattle, Washington; and CVS Caremark, Scottsdale, Arizona, USA. Supported by grant K12HS019482 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. S. Ringold, MD, MS, Seattle Children’s Hospital, Pediatrics; S. Grant, MS, Axio Research LLC; C. Girdish, MPH, CVS Caremark; C.A. Wallace, MD, Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; S.D. Sullivan, PhD, University of Washington Department of Pharmacy. Address correspondence to Dr. S. Ringold, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98015, USA. E-mail: Sarah.Ringold@seattlechildrens.org Accepted for publication September 26, 2012.
Shannon Grant
From Seattle Children’s Hospital, Pediatrics; Axio Research LLC; Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; University of Washington Department of Pharmacy, Seattle, Washington; and CVS Caremark, Scottsdale, Arizona, USA. Supported by grant K12HS019482 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. S. Ringold, MD, MS, Seattle Children’s Hospital, Pediatrics; S. Grant, MS, Axio Research LLC; C. Girdish, MPH, CVS Caremark; C.A. Wallace, MD, Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; S.D. Sullivan, PhD, University of Washington Department of Pharmacy. Address correspondence to Dr. S. Ringold, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98015, USA. E-mail: Sarah.Ringold@seattlechildrens.org Accepted for publication September 26, 2012.
Charmaine Girdish
From Seattle Children’s Hospital, Pediatrics; Axio Research LLC; Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; University of Washington Department of Pharmacy, Seattle, Washington; and CVS Caremark, Scottsdale, Arizona, USA. Supported by grant K12HS019482 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. S. Ringold, MD, MS, Seattle Children’s Hospital, Pediatrics; S. Grant, MS, Axio Research LLC; C. Girdish, MPH, CVS Caremark; C.A. Wallace, MD, Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; S.D. Sullivan, PhD, University of Washington Department of Pharmacy. Address correspondence to Dr. S. Ringold, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98015, USA. E-mail: Sarah.Ringold@seattlechildrens.org Accepted for publication September 26, 2012.
Carol A. Wallace
From Seattle Children’s Hospital, Pediatrics; Axio Research LLC; Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; University of Washington Department of Pharmacy, Seattle, Washington; and CVS Caremark, Scottsdale, Arizona, USA. Supported by grant K12HS019482 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. S. Ringold, MD, MS, Seattle Children’s Hospital, Pediatrics; S. Grant, MS, Axio Research LLC; C. Girdish, MPH, CVS Caremark; C.A. Wallace, MD, Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; S.D. Sullivan, PhD, University of Washington Department of Pharmacy. Address correspondence to Dr. S. Ringold, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98015, USA. E-mail: Sarah.Ringold@seattlechildrens.org Accepted for publication September 26, 2012.
Sean D. Sullivan
From Seattle Children’s Hospital, Pediatrics; Axio Research LLC; Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; University of Washington Department of Pharmacy, Seattle, Washington; and CVS Caremark, Scottsdale, Arizona, USA. Supported by grant K12HS019482 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. S. Ringold, MD, MS, Seattle Children’s Hospital, Pediatrics; S. Grant, MS, Axio Research LLC; C. Girdish, MPH, CVS Caremark; C.A. Wallace, MD, Children’s Hospital and Medical Center, Rheumatology and Infectious Diseases; S.D. Sullivan, PhD, University of Washington Department of Pharmacy. Address correspondence to Dr. S. Ringold, Seattle Children’s Hospital, 4800 Sandpoint Way NE, Seattle, WA 98015, USA. E-mail: Sarah.Ringold@seattlechildrens.org Accepted for publication September 26, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Methotrexate and Injectable Tumor Necrosis Factor-α Inhibitor Adherence and Persistence in Children with Rheumatic Diseases
Sarah Ringold, Shannon Grant, Charmaine Girdish, Carol A. Wallace, Sean D. Sullivan
The Journal of Rheumatology Nov 2012, jrheum.120753; DOI: 10.3899/jrheum.120753